Veterinary and Comparative Oncology

Papers
(The median citation count of Veterinary and Comparative Oncology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma22
Issue Information16
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours15
Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?14
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours14
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma14
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy13
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy13
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy13
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment13
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)12
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs12
Practice patterns about the role of palliation in veterinary surgical oncology12
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain11
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study11
Blood biomarkers for canine cancer, from human to veterinary oncology11
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping11
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study11
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma10
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review10
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria10
Efficacy and adverse events of continuousl‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin10
9
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tu9
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells8
Issue Information8
Cover Image8
Corrigendum8
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs8
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas8
Author Index7
Issue Information7
Issue Information7
Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus7
7
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs7
Issue Information6
6
6
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours6
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs6
Frontal sinus carcinoma in forty‐one dogs (2001–2022)6
Issue Information6
Issue Information6
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain6
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma6
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs6
Issue Information5
Outcome and postoperative complications in 73 dogs with thyroid carcinoma with gross vascular invasion managed with thyroidectomy5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment5
5
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire5
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk5
Comparison of the anticancer effects of various statins on canine oral melanoma cells5
5
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma5
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)5
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma5
Author Index5
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs4
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma4
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry4
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases4
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience4
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance4
4
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs4
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study4
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma4
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis4
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study4
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review4
Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”3
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases3
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study3
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells3
Exploring optical coherence tomography imaging depth to differentiate tissues at surgical margins3
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases3
Issue Information3
Evaluating the relevance of surgical margins. Part one: The problems with current methodology3
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs3
Cyclical 10‐day dosing of melphalan for canine multiple myeloma3
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma3
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours3
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade3
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma3
3
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy3
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission3
VCS abstract3
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases3
The animal's microbiome and cancer: A translational perspective3
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study3
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol3
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours3
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease2
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy2
Issue Information2
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma2
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas2
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration2
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles2
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway2
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy2
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study2
Axillary lymphadenectomy in dogs: A description of surgical technique2
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes2
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma2
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay2
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour2
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology2
VCS 2024 Abstracts2
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria2
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines2
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas2
2
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate2
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours2
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas2
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study2
The prognostic significance of metabolic tumour volume and total lesion glycolysis for dogs staged for appendicular osteosarcoma with fluorine‐18 fluorodeoxyglucose positron emission tomography/comput2
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?2
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies2
Issue Information2
Cover Image2
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component2
Author Index1
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs1
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour1
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors1
An aggressive CD4CD8 T‐cell neoplasm in young English bulldogs1
Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment1
Intraoperative assessment of canine soft tissue sarcoma by deep learning enhanced optical coherence tomography1
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours1
Prostaglandin EP4 receptor mRNA expression in canine lymphoma1
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma1
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients1
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours1
Issue Information1
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study1
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)1
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours1
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey1
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study1
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases1
1
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report1
Expression and prognostic value of TRPM7 in canine mammary tumours1
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma1
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy1
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma1
Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution 1
1
Issue Information1
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus1
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma1
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐1181
Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)1
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines1
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours1
A retrospective analysis of 11 dogs with surface osteosarcoma1
Response of canine thyroid carcinomas to radioiodine1
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy1
1
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma1
Surgical complications following sentinel lymph node biopsy guided by γ‐probe and methylene blue in 113 tumour‐bearing dogs0
Organoids of patient‐derived medullary thyroid carcinoma: The first milestone towards a new in vitro model in dogs0
Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation0
Issue Information0
Histologic, Phenotypic, and Molecular Characterization of Feline Hodgkin‐Like Lymphoma With Classical Reed‐Sternberg Cells0
0
Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case–control study0
Lymphoid Aggregates in Canine Cutaneous and Subcutaneous Sarcomas: Immunohistochemical and Gene Expression Evidence for Tertiary Lymphoid Structures0
Author Index0
Antioxidant 1 copper chaperone gene expression and copper levels in dog osteosarcoma patients0
Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma0
Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases0
Characterization of the dissemination of canine cancer misinformation on YouTube0
Outcomes and Perioperative Complications of Surgical Resection on Canine Carotid Paragangliomas (21 Cases): A Veterinary Society of Surgical Oncology Study0
Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small‐Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma0
Radiation toxicity grading after chemoradiotherapy of canine urinary tract carcinomas: Comparing VRTOG to VRTOG_v2.00
Effective detection of BRAFV595E mutation in canine urothelial and prostate carcinomas using immunohistochemistry0
Molecular phenotyping of malignant canine mammary tumours: Detection of high‐risk group and its relationship with clinicomolecular characteristics0
Facilitating stakeholder involvement in Comparative Oncology research: A qualitative analysis of key stakeholder opinions and perceptions0
0
Correction to: Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment0
Reduced Klotho expression and its prognostic significance in canine hepatocellular carcinoma0
Establishment of aBRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects ofMEKinhibitors against canine prostate cancer0
Cover Image0
Hypoxia‐targeting therapy for intestinal T‐cell lymphoma in dogs: Preclinical study using 3D in vitro models0
Feline high‐grade and large granular lymphocyte alimentary lymphomas treated with COP‐ or CHOP‐based chemotherapy: A multi‐centric retrospective study of 57 cases0
Elevated expression of miR‐301a and its functional roles in canine oral melanoma0
Homoharringtonine induces apoptosis of mammary carcinoma cells by inhibiting the AKT/mTOR signaling pathway0
Abstracts‐Posters0
DNA damage response proteins in canine cancer as potential research targets in comparative oncology0
Author Index0
The second‐generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells0
Relative Tumour Volume in Canine Oral Melanoma Staging and Prognosis0
Mastocytosis in the skin in dogs: A multicentric case series0
Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology‐Pathology Working Group0
Evaluation of Serum Level of Chemokine (C‐C Motif) Ligand 2 (CCL2) in Canine Urothelial Carcinomas, Mast Cell Tumours, and Insulinomas, and Its Correlation With Circulating Monocytes0
A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy0
Stromal Expression Profiling Reveals Immune‐Driven Adaption to Malignancy in Canine Melanoma Subtypes0
0
Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma0
Histologic grade has a higher‐weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes0
Canine squamous cell carcinoma: Electrochemotherapy association with surgery and correlation with overall survival0
Author Index0
Distribution of Inflammatory Infiltrate in Feline Mammary Lesions: Relationship With Clinicopathological Features0
Retrospective evaluation of toceranib phosphate (Palladia) in the treatment of canine carcinomatosis and mesothelioma0
0
Issue Information0
Issue Information0
Extracellular heat shock protein 70 levels in tumour‐bearing dogs and cats treated with radiation therapy and hyperthermia0
Establishment and characterization of two novel patient‐derived lines from canine high‐grade glioma0
Long non‐coding RNA and transfer RNA‐derived small fragments in exosomes are potential biomarkers for canine oral melanoma0
0
Location of the targeted lymph node in a mandibular lymphocentrum: A needle aspiration model in canine cadavers0
Expression of mPGES1 and p16 in feline and human oral squamous cell carcinoma: A comparative oncology approach0
Effect of proteasome inhibitors on canine lymphoma cell response to CHOP chemotherapy in vitro0
Comparative Transcriptomes of Canine and Human Prostate Cancers Identify Mediators of Castration Resistance0
Body Composition Measurements as Predictive Variables for Outcomes of Canine Appendicular Osteosarcoma Treated With Stereotactic Body Radiation Therapy0
Statins downregulateYAPandTAZand exert anti‐cancer effects in canine mammary tumour cells0
Issue Information0
Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) loss in canine mammary carcinoma0
Prophylactic Antimicrobials for Prevention of Febrile Neutropenia in Tumour‐Bearing Dogs Treated With Lomustine0
Identification of hypoxia‐induced metabolism‐associated genes in canine tumours0
Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items0
Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial–mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro0
Characterization and function of extracellular vesicles in a canine mammary tumour cell line: Ultracentrifugation versus size exclusion chromatography0
Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumours0
Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence0
SLUG is upregulated and induces epithelial mesenchymal transition in canine oral squamous cell carcinoma0
Issue Information0
Correction to: Standardization of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria0
Comparison of response assessment in veterinary neuro‐oncology and two volumetric neuroimaging methods to assess therapeutic brain tumour responses in veterinary patients0
Atorvastatin preferentially inhibits the growth of high ZEB‐expressing canine cancer cells0
Large granular lymphocyte lymphoma in 65 dogs (2005–2023)0
The role of companion animal models in radiopharmaceutical development and translation0
Prevalence and anatomopathological characterization of cutaneous squamous cell carcinomas with regional and distant metastases in dogs and cats: 20 cases (1985–2020)0
mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders0
Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer0
Comparison of Fine‐Needle Aspiration and Core Needle Biopsy for the Pre‐Operative Diagnosis of Canine and Feline Mammary Gland Tumours0
The Poly (ADP‐Ribose) Polymerase‐1 Enzyme Is Overexpressed in Various Solid Canine Tumours: An Immunohistochemical Study0
Magnetic resonance and computed tomographic imaging characteristics and potential molecular mechanisms of feline meningioma associated calvarial hyperostosis0
0.050193071365356